🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Myelofibrosis

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms NCT06063486Phase 22 sites📍 Los Angeles📍 Los Angeles University of Southern California · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Curcumin/ Demethoxycurcumin/Bisdemethoxycurcumin-co… Asian Myeloproliferative Neoplasm (MPN) Registry NCT05882773n/a1 site📍 Hong Kong The University of Hong Kong Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810Phase 12 sites📍 Scottsdale📍 Rochester Mayo Clinic · Tests: Axl/Mer/CSF1R Inhibitor Q702, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography Evaluating Safety ,Tolerability, Pharmacokinetic,Efficacy of WJ01024 or WJ01024 Combined With Ruxolitinib in Patients With Myelofibrosis NCT07802405Phase 11 site📍 Zhengzhou Henan Cancer Hospital · Tests: WJ01024 tablet Study of INCA036978 in Participants With Myeloproliferative Neoplasms NCT07441694Phase 154 sites📍 Birmingham📍 Irvine📍 Los Angeles Incyte Corporation · Tests: INCA036978, Standard disease-directed therapy To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects NCT07480824Phase 12 sites📍 Luoyang📍 Jinan Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Tests: TQ05105 Allo HSCT Using RIC and PTCy for Hematological Diseases NCT05805605Phase 21 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: Peripheral Blood Stem Cell Transplant, Allopurinol 300 MG, Fludarabine, Cyclophosphamide, Bone Marrow Cell Transplant Combination of Tagraxofusp With Pacritinib in Patients With Intermediate-1 or Higher Myelofibrosis, Who Have Had Prior Therapy With the Approved JAK Inhibitors or in Which Therapy With the Approved JAK Inhibitors is Not Appropriate, Contraindicated or Declined NCT06414681EARLY Phase 11 site📍 Fairway University of Kansas Medical Center · Tests: Tagraxofusp, Pacritinib Research Platform Myelofibrosis and Anemia NCT06976918n/a1 site📍 Multiple Locations iOMEDICO AG Role of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells NCT06896344n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia · Tests: In vitro culture A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis NCT07551427Phase 224 sites📍 Hefei📍 Fuzhou📍 Guangzhou Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Tests: TQ05105 Tablets (Rovadicitinib Tablets) 18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study. NCT06164561n/a1 site📍 Hangzhou First Affiliated Hospital of Zhejiang University Myeloproliferative Neoplasms (MPNs) Patient Registry NCT02760238n/a1 site📍 Toronto University Health Network, Toronto · Tests: Observational A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis NCT07317700Phase 32 sites📍 Chengdu📍 Tianjin Chengdu Zenitar Biomedical Technology Co., Ltd · Tests: Flonoltinib 75mg, Ruxolitinib Phosphate Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia NCT07394153Phase 213 sites📍 Barcelona📍 Barcelona📍 Barcelona Grupo Español de Enfermedades Mieloproliferativas Crónicas … · Tests: Pacritinib Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF) NCT06327100Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Ruxolitinib, Tasquinimod A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis NCT04176198Phase 1, Phase 291 sites📍 Birmingham📍 Tucson📍 Duarte Sumitomo Pharma America, Inc. · Tests: Nusivertib, Ruxolitinib, Momelotinib Clonal Architecture of ASXL1-mutated Myelofibrosis NCT05710211NA13 sites📍 Angers📍 Brest📍 Cholet University Hospital, Angers · Tests: Clonal architecture determination TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT NCT07302776Phase 11 site📍 Palo Alto Stanford University · Tests: Tacrolimus, Early Tacrolimus Taper Strategy Momelotinib During and After HCT in Myelofibrosis NCT07104799Phase 11 site📍 Boston Massachusetts General Hospital · Tests: Momelotinib A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) NCT06661915Phase 231 sites📍 Irvine📍 Orange📍 Palo Alto National Cancer Institute (NCI) · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Decitabine and Cedazuridine, Iadademstat Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue) NCT06053671NA1 site📍 London King's College Hospital NHS Trust · Tests: Blood and nasal swab sampling Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis. NCT05440838n/a6 sites📍 Angers📍 Brest📍 Nantes University Hospital, Angers · Tests: Next-generation sequencing Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders NCT04644016Phase 21 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: Clofarabine, Fludarabine, Busulfan, Cyclosporine-A, Mycophenolate Mofetil A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation NCT06859424Phase 213 sites📍 Birmingham📍 Duarte📍 Palo Alto Center for International Blood and Marrow Transplant Resear… · Tests: Conditioning Regimen A, Conditioning Regimen B, Conditioning Regimen C, Conditioning Regimen D, Conditioning Regimen E Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm NCT07590986n/a1 site📍 Brussels Université Catholique de Louvain Motor Development and Early Predictors of Psychomotor Outcomes in Preterm and Term Infants Assessed by MOS-R and Caregiver Questionnaire at 18 and 36 Months NCT07296003n/a3 sites📍 Pardubice📍 Pardubice📍 Pardubice Masaryk University · Tests: Vojta method A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia NCT05980806Phase 270 sites📍 Duarte📍 Columbia📍 New York Karyopharm Therapeutics Inc · Tests: Selinexor 60 mg, Selinexor 40 mg, Ruxolitinib, Pacritinib, Momelotinib AlloHCT With PegINFa for Myelofibrosis NCT05535764Phase 11 site📍 Salt Lake City University of Utah · Tests: Pegylated interferon alpha2a A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept NCT07419178NA1 site📍 Parma Azienda Ospedaliero-Universitaria di Parma · Tests: Diagnosis of MPN subtypes
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy